Health data are often not symmetric to be adequately modeled through the usual normal distributions; most of them exhibit skewed patterns. They can indeed be modeled better through the larger family of skew-normal distributions covering both skewed and symmetric cases. However, the existing likelihood based inference, that is routinely performed in these cases, is extremely non-robust against data contamination/outliers. Since outliers are not uncommon in complex real-life experimental datasets, a robust methodology automatically taking care of the noises in the data would be of great practical value to produce stable and more precise research insights leading to better policy formulation. In this paper, we develop a class of robust estimators and testing procedures for the family of skew-normal distributions using the minimum density power divergence approach with application to health data.
Introduction
Health science is an integral part of medical research where the objective is to improve the quality of human (as well as animal) health through appropriate scientific insight generation and necessary policy implementation. The backbone of health science research is the efficient analyses of heath data obtained from several designed or observational medical experiments or surveys with appropriate target questions in mind. The innovations and insights generated from such analyses are essential in medical research to develop cures to any sort of illness and ensure better health quality; they are also important for any country (and even globally) to prepare appropriate health policies.
Often, the conventional statistical distribution used in modeling different kinds of health data is the bellshaped and symmetric normal distribution. Although it works for some health measurements like height or weight of patients, etc., most health data, specially those measured on some clinical metrics, often exhibit empirical skewness so that the conventional normal distribution can not be used to model/analyze them [? ] . Among several possible parametric distributions to model skewed data, possibly the most popular one is the Azzalini-type Skew Normal (SN) distribution family [1] [2] [3] [4] which also covers the usual symmetric normal distribution as a special case; see Figure 1 for a wide variety of distributional shapes (densities) of the SN distribution obtained by varying the shape parameter. Lately, this SN distribution has been successfully applied to model and analyze different types of recent biomedical data [5? -23] . In this paper, we focus on the SN distribution family for modeling data from different health measurements under one umbrella and on the inference using the estimators of the corresponding SN parameters. The SN distribution is defined in terms of three parameters, namely the location parameter µ ∈ R, the scale parameter σ ∈ R + and the skewness parameter γ ∈ R, and is denoted by SN (µ, σ, γ). In particular, if µ = 0 and σ = 1, it is referred to as the standard SN distribution and is denoted by SN (γ). The probability density function (pdf) and the cumulative distribution function (cdf) of the SN(µ,σ,γ) distribution are given, respectively, as
where θ = µ, σ, γ T is the vector of unknown parameters, φ and Φ are the pdf and the cdf of the standard normal distribution, respectively, and T (h, a) is Owen's function defined as
1 + x 2 dx, h, a ∈ R.
The mean, variance and skewness (γ 1 ) of a random variable X having SN(µ,σ,γ) distribution are given by E(X) = µ+σδ 2 π , V ar(X) = σ 2 1 − 2δ 2 π , with δ = γ(1 + γ 2 ) −1/2 , and γ 1 = (4−π)γ 3 2( π 2 +( π 2 −1)γ 2 ) 3/2 . Clearly, the SN distribution is positively and negatively skewed according to the sign of the parameter γ; see Figure 1 . At the particular case γ = 0, the SN distribution SN (µ, σ, 0) has skewness zero and coincides with symmetric normal distribution, N (µ, σ 2 ), having mean µ and variance σ 2 .
Given a random sample X 1 , . . . , X n from a skewed population, we can fit the SN distribution by estimating the parameters θ = µ, σ, γ T based on the observed data and the subsequent inference can be done based upon these estimates. The usual method of estimation under SN model is the maximum likelihood estimator (MLE) which is asymptotically the most efficient at the model. But, a major drawback of the MLE is its extreme non-robust nature against data contaminations, outliers or model misspecifications; this further makes all the MLE based inference highly unstable yielding incorrect insights. However, it is not unusual to have some outlying observations in modern complex datasets due to several external or erroneous factors/activities. Hence, a robust inference procedure automatically taking care of the noises (outliers)
in the data would be of great practical value to produce stable and more precise research insights leading to better policy formulation. To further motivate our work in the context of health data analyses, let us consider the following real data example.
A Motivating Example (AIS data):
We consider the data on health measurements of 706 Australian athletes from 12 different sports which were collected at the Australian Institute of Sports (AIS) in 1990 by Telford and Cunningham [24] to investigate the relationships of the five routine hematological measures, namely the hemoglobin concentration (HC), hematocrit (H), red cell count (RCC), white cell count (WCC) and plasma ferritin concentration (PFC) in the blood of these athletes with their height (Ht), weight (Wt) and the sports type. These measurements are recorded on 1604 occasions from each athletes based on the blood samples collected from their forearm vein amidst periods of moderate to intense training but at least 6 hours after a training session. Some important derived health measurements like body-mass index (BMI) and lean body mass (LBM) are also reported.
The data were later used by several researchers in different statistical inference problems; in particular, few of them fitted the SN distribution with MLE but only to a few measurements and/or a part of the data [21, 25] . However, the use of SN distribution for modeling the health measurements and its skewness is indeed justifiable through its distributional structure as well as technically from the concept of selective sampling [3, 26] . For a brief explanation, suppose that we want to model a health measurement variable U 1 , which is assumed to be standardized for simplicity. In most cases, health data are collected from a random sample 5 of an appropriately defined subpopulation satisfying a minimum health standard; in the above example of AIS data all observations are collected from trained athletes who are known to be healthier than others (in some appropriate health measurement scale). Suppose such subpopulation is defined in terms of the condition U 0 > τ for a population random variable U 0 ; without loss of generality we may assume U 0 to be also standardized. Assume τ = 0, U 0 is normally distributed and has a correlation ρ with U 1 . Then, even if U 1 is normally distributed in the population, its distribution over the subpopulation, i..e, conditional distribution given U 0 > 0 is indeed SN(γ) with γ = ρ(1 − ρ 2 ) −1/2 . It can only be symmetric if the target variable is uncorrelated with sub-population defining variable U 0 .
Therefore the SN distribution is inevitable in health data analyses and it is the MLE which makes the ultimate inference erroneous under data contamination. Therefore, it is important to develop an appropriate robust inference methodology for the SN distribution family. Unfortunately, little attention has been paid on this issue in the literature, except for a few discrete attempts for some particular applications only [27] [28] [29] [30] .
In this paper, we develop a simple yet highly efficient robust inference procedure for the SN distribution that can even be generalized to any complex inference problem associated with skewed data quite easily.
Among several approaches to robust inference, we consider the minimum distance approach to estimate the parameters of the SN distribution by minimizing an appropriate divergence (distance) measure between the data and the model density. In particular, we consider the density power divergence (DPD) measure [31] which has lately been extremely popular because of generating extremely robust estimators along with high asymptotic efficiency [32] [33] [34] [35] [36] [37] [38] [39] . In this paper, we first define the minimum DPD estimator (MDPDE) of the parameters of the SN distribution based on a random sample and discuss its asymptotic properties like consistency and asymptotic normality. Their asymptotic variance can then be consistently estimated to obtain the standard errors of our proposed estimators and their robustness properties are discussed through the influence function analysis. Since there are complexity in the computation of the MLE itself for SN distribution [25] , the computation of the MDPDE is also challenging; we have developed an efficient algorithm for this purpose using the concept of Genetic Algorithm [40] . We next develop a robust Wald-type test based on the proposed MDPDE along with their asymptotic and robustness properties. The important particular case of testing the hypothesis of symmetry (γ = 0) under the SN alternatives are discussed in great detail.
The fixed-sample performances of the proposed estimation and testing procedures are illustrated through extensive simulation studies. Our proposals are then applied to reanalyze the motivating AIS dataset as well as to analyze data from an AIDS clinical trial for robust inferential insights. Finally the paper ends with some concluding discussion about our work and its possible future extensions. 6 
Estimating Equation
The DPD family [31] is indexed by a single tuning parameter α ≥ 0, controlling the trade-off between robustness and efficiency. For two densities g and f , both being absolutely continuous with respect to some common dominating measure µ, the DPD measure between g and f is defined as
Note that, the DPD at α = 0 is nothing but the well-known Kullback-Leiber divergence (KLD) associated with the likelihood approach. We need to minimize the DPD measure between the estimated data density and the postulated model density to obtain the "best fitted" model and the corresponding parameter estimates.
Suppose we have a random sample X 1 , . . . , X n from a population having true density g with the associated distribution function G (with the associated measure µ being the Lebesgue measure). We wish to model them by the SN distribution having density f θ and distribution function F θ , which are given in (1) and (2), respectively. Then, the minimum DPD estimator (MDPDE) of the unknown model parameter θ is to be obtained by minimizing d α ( g, f θ ) over the parameter space Θ = R × R + × R, where g is an estimate of g based on the observed sample. One major advantage of the DPD measure is that we can avoid estimating density g by nonparametric smoothing, which often has several complications like bandwidth selection, curse of dimensionality etc. This is because we can rewrite the form of the DPD from (3) as
where the last term K = 1 α g 1+α dµ is independent of the parameter θ and has no effect in our target minimization with respect to θ ∈ Θ. Noting that the second term can be estimated just by plugging in the empirical estimate of G, namely the empirical CDF obtained based on the sample X 1 , . . . , X n , the MDPDE can be obtained by minimizing the simpler objective function
measure, the above MDPDE objective function has the form
Note that, the integral part of the objective function (5) do not have a tractable closed-form expression, and hence we need to compute it numerically during the simultaneous minimization of H n (µ, σ, γ) with respect to the three parameters (µ, σ, γ). By standard differentiation, we get the estimating equations of our MDPDE as given by
where u θ (x) = ∂ ∂θ log f θ (x) is the score function of the SN distribution and has the form
and
Clearly there is no closed form solution of the above MDPDE estimating equations in (6) and we need to solve them numerically in order to obtain the MDPDEs based on a given sample. An efficient method for the computation of the MDPDE is dicussed later in Section 3.
It is important to note that the MDPDE is indeed an M-estimator, since its estimating equation can be written in the form i ψ(X i , θ) = 0 for a model based ψ-function; see Equation (6) 
Asymptotic Efficiency and Standard Error
The asymptotic distribution of the MDPDE for the present case of the SN distribution can easily be obtained from its general theory or the M-estimation theory. In particular, the minimum DPD estimators are √ nconsistent and asymptotically normal. At a given α ≥ 0, if the corresponding MDPDE obtained based on a random sample of size n is denoted by θ α,n , and the true parameter value is θ 0 , we have
where 0 p is a p-vector with all entries zero and
where ξ α (θ) and f θ are as defined in (8) and (1), respectively, and
Here we can see that the above integrals do not have a closed form, but we can numerically calculate them to compute the asymptotic variance matrix at different given values of α and θ. Based on these formulas, we
can study the asymptotic relative efficiency (ARE) of the proposed MDPDE which are presented in Table 1 at different values of θ = (µ, σ, γ) T for the SN distribution. Note that, these AREs decrease with increasing α but the loss in efficiency is not quite significant at small positive α. The above asymptotic variance formula can also help us to obtain the standard errors of the MDPDEs in any practical application. For the MDPDE θ α,n = ( µ α,n , σ α,n , γ α,n ) T , obtained based on a sample of size n, its standard errors are given by Σ
α (θ 0 )/n and Σ 
Robustness: Influence Function Analysis
The robustness of an estimator can be theoretically examined through the classical influence function (IF)
analysis [41] . The IF indeed measures the asymptotic (standardized) bias of the estimator caused by an infinitesimal contamination at a distant contamination point (say y). Therefore, the boundedness of the IF over the contamination point y restricts the extent of possible bias finitely for the corresponding estimator indicating its robust nature (sometime also referred to as B-robustness to emphasis the boundedness of bias).
On the other hand, an unbounded IF indicates possible unbounded bias and non-robustness of the estimator.
Further, with similar intuition, the supremum of the absolute IF taken over all possible contamination points naturally indicates the extent of (bias) robustness of the corresponding estimator.
From the theory of M estimator [41] or that of the general MDPDE [31, 32] , one can obtain the influ-ence function of the MDPDE functional, say T α for a tuning parameter α, under the present case of SN distribution which is given by
where ξ α and J α are defined as in (8) and (9), respectively. Now, the form of the SN density f θ in (1) and the corresponding score function u θ in (7) clearly indicates that the above IF is bounded in y for all α > 0 and unbounded at α = 0. We have presented the IFs of the three parameters (µ, σ, γ) in Figure 3 In order to compute the MDPDE, we need to minimize the objective function in (5) simultaneously with respect to the three parameters (µ, σ, γ), or equivalently solve the three estimating equations given in (6) .
These are not straightforward numerical exercises due to the complex form of the objective function and standard numerical procedures like Newton-Raphson algorithm fail. It is indeed also a known problem in case of the computation of the MLE for the SN distribution as well, for which some advanced numerical procedures has been tried in the literature. Here, we describe two possible efficient algorithms for the computation of our MDPDE at any given α > 0.
Genetic Algorithm
The genetic algorithm (GA) has been successfully applied for the computation of the MLE under the SN model by [25] . The GA is an useful and appropriately designed randomized search technique to find exact or approximate solutions in an optimization problem. Although John Holland first introduced this algorithm in 1960, it has become popular lately through the works of David Goldberg and others with divergent applications [40, 42] . The name unsurprisingly came from its structural similarity with genetic mutations and crossover across generations following the basic principle of the Darwinian Theory of "Survival of the Fittest".
For an optimization problem, we need to consider an appropriate fitness function (often the objective function itself) which produce the fitness value of each possible (candidate) solution under the objective criterion.
Then, in brief, the GA starts with an initial set of candidate solutions (chromosomes) and iterates over the subsequent generations to produce new sets of solutions (chromosomes) through recombination and mutation where the solutions with better fitness values have a higher chance to be there in the subsequent generation so that the objective function is improved towards optimality.
To compute the MDPDE using GA, we consider the objective function H n (θ) = H n (µ, σ, γ) as the fitness function with lower values indicating greater fitness of the solution vector H n (θ = (µ, σ, γ). Then, the algorithm traverses through the following steps.
GA for Computation of the MDPDE:
Step 1. We start with an initial set of N candidate solutions denoted as
Step 2. Compute the fitness function H n (θ) for each solutions in P (m) = {θ
Step 3. From the set P (m) , we choose some parent solutions to generate new solutions (offsprings) through the 'Fitness Proportionate Selection' scheme, where the probability of selection is proportional to the (better) fitness values.
Alternative schemes like 'Roulette Wheel Selection' or 'Tournament Selection' [43] can also be used.
Step 4. We form a new set of N candidate solutions, denoted as
the next iteration (generation) using the following two steps:
Step 4.1. We choose a specific number (say N E ) of elite solutions (survivor) from P (m) which are carried forward over the next iteration (generation) without any alterations. They are again chosen by the criterion of having best fitness values.
Step 4.2. For generating remaining (N −N E ) candidate solutions for next generations, we perform crossover and mutation operations (through some weighted combination) to the solutions from P (m) according to some pre-specified crossover probability (P C ) and mutation probability (P M ). The crossover leads the solutions to a convergence while mutation increases diversity among the solutions to avoid being stuck at a local optima.
Step 5. Set m = m + 1 and go to Step 2.
Step 6. Repeat Step 2 to Step 5, until an appropriate (pre-specified) convergence criteria is satisfied.
When stopped, the fittest solution in the last iteration (generation) is returned as the optimal solution (the MDPDE).
Note that, in order to implement the above G, we need to first specify the necessary tuning parameters N, N E , P C , M P ; it is suggestive to take N E as 5% of N , a higher value of P C and a lower values of P M for faster convergence [40] . In all our numerical experiments (simulation studies), we have used the R package 'GA' to implement the Genetic Algorithm with N = 50, N E = 2, P M = 0.1, P C = 0.8 and a maximum of 5000 iterations (generations) as stopping criterion. However, one challenge using this approach is to choose appropriate values of these tuning parameters for any real life application!
Gradient Descent Method
The method of gradient descent is another popular first-order iterative optimization algorithm mostly used in Machine Learning [44, 45] . To find the minimum of the an objective function, this method progresses iteratively by updating the parameter values taking steps proportional to the negative of the gradient (first order derivative) of the objective function. For choosing these steps in each iteration, there are various types of algorithms available in the literature [46, 47] . It is important to note here that this gradient descent approach might converge to just to a local minimum depending on the initial parameter value considered;
however, if the function is convex, which is mostly the case for our MDPDE, we expect to achieve the global minimum by starting with any reasonable initial value.
Considering again the MDPDE objective function H n (θ) = H n (µ, σ, γ), the gradient descent algorithm can be used to find its minimum, i.e., the required MDPDE, through the following steps:
Gradient Descent for Computation of the MDPDE:
Step 1. Start with an initial parameter value θ 0 =(µ 0 ,σ 0 ,γ 0 ) and a step size (tuning parameter) λ > 0.
Set m = 0.
Step 2. Calculate ∇H n (θ m ), the derivative of the function H n (θ) with respect to θ evaluated at the point θ m (the solution at the m th step of iteration).
Step 3. Update the solution at (m + 1) th step as: θ m+1 = θ m − λ∇H n (θ m ).
Step 4. Set m = m + 1 and go to Step 2.
Step 5. Repeat Step 2 to Step 4, until an appropriate convergence criteria is satisfied.
Here, we only need to choose one tuning parameter λ for the gradient descent algorithm and there exist several suggestions for its optimum selection; see, e.e, [48, 49] . For all our numerical illustrations here, we have taken λ=0.04, and the initial parameter value to be the maximum partial likelihood estimates of θ = (µ, σ, γ), obtained by using the R function 'sn.mple', and the convergence criterion as no significant 
General Theory for Composite Hypotheses
We now consider the problem of testing statistical hypotheses. Suppose that, based on random sample X 1 , . . . , X n from the SN distribution, we want to test the composite hypothesis
for some closed subset Θ 0 of the parameter space Θ. In most applications, the restricted (null) parameter If θ α,n denote the MDPDE of θ based on the given sample, the Wald-type test statistic for testing the hypothesis (12) is given by
where J α and K α are as defined in (9) and (10), respectively. At α = 0, this Wald-type test statistics coincides with the usual Wald test based on the MLE.
From the asymptotic distribution of the MDPDE θ α,n in Section 2.2, it immediately follows that W α,n asymptotically follows a (central) chi-squared distribution, χ 2 r , with r degrees of freedom under the null hypothesis in (12) . Therefore, we reject H 0 in (12) at τ 0 level of significance if W α,n ≥ χ 2 r,τ0 , the upper
From the general theory of Basu et al. [33] , the MDPDE based Wald-type test is consistent at any fixed alternatives. Under the contiguous hypothesis of the form H 1,n : θ n = θ 0 + n −1/2 d, with θ 0 ∈ Θ 0 and d ∈ R 3 \ {0 3 }, W α,n asymptotically follows a non-central chi-squared distribution, denoted as χ 2 r,δ , having r degrees of freedom and the non-centrality parameter δ = d T Q α θ 0 d, with Q α θ 0 = power function of the test based on W α,n can be calculated as Π α θ n = 1 − G χ 2 r,δ χ 2 r,τ0 , where G χ 2 r,δ is the cdf of the χ 2 r,δ distribution.
The robustness properties of the MDPDE based Wald-type tests were first discussed by [39] for general parametric models, which also hold for our SN distribution case. For completeness, we restate the main results briefly. At the null distribution with θ 0 ∈ Θ 0 , the first order IF of the Wald-type test statistic is inconclusive (identically zero) but the second order IF has the form (14) will then be bounded in the contamination point y for any α > 0 which implies the robustness of the test based on the MDPDE based statistics in (13) .
Again from the general theory of [39] , one can see the robustness of the level and power of the MDPDE based Wald-type tests for any α > 0 through their bounded level influence function (LIF) and the power influence function (PIF). In particular, the LIF of any order is identically zero and the PIF for testing at the significance level τ 0 has the form
where 
Robust Test for Symmetry
We now discuss, in detail, a particular testing problem in the context of SN distribution, namely the test of symmetry through the null hypothesis H 0 : γ = 0. Let us consider a slightly general problem of testing
for a pre-fixed real γ 0 . Note that, the choice γ 0 = 0 yields the test for symmetry against the SN alternatives.
Note that, here µ and σ are unknown nuisance parameters. In the notation of Section 4.1, we have Θ 0 = θ = (µ, σ, γ) T : µ ∈ R, σ ∈ R + , γ = 0 , r = 1, m(θ) = γ − γ 0 and M (θ) = (0, 0, 1) T .
Denoting the MDPDE as θ α,n = µ α,n , σ α,n , γ α,n , our MDPDE based Wald-type test statistics (13) has a simplified form for testing (16) which is given by
where Σ (33) α (θ) is the (3, 3)-th element of Σ α (θ). Then, under the null hypothesis in (16) , W α,n asymptotically follows χ 2 1 distribution and the test can be performed by comparing W α,n with the corresponding critical values. Further, the approximate expression of power function at the contiguous hypothesis of the form H 1,n : γ = γ 0 + n −1/2 d, with d ∈ R, is given by
We have numerically calculated this asymptotic contiguous power for testing symmetry (γ 0 = 0) at 5% level of significance by the MDPDE based Wald-type test with different values of α, which are presented in Table   2 for θ 0 = (0, 1, 0) T . It is clear that, just like the ARE of the MDPDE, the contiguous power of the MDPDE based test also decreases as α increases but this loss is not quite significant at small α > 0. For larger values of d, i.e., alternatives further away from the null, the power eventually becomes one for all α ≥ 0 in accordance with the consistency of these tests. .00 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.9998 0.9993 9.00 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.9999
Next the robustness of the Wald-type test based on the statistic (17) for testing (16) can be studied through the second order influence function of the test statistics and the PIF. From the general formulas presented in Section 4.1, we can easily calculate these measures in the present case of testing (16) as given by
where T under each scenario in Table 4 . One can clearly note that the bias and MSE under pure data increases with α but the increase is 
Performance of the MDPDE based Wald-type test
To visualize the performance of proposed MDPDE based Wald-type tests, we have again performed several simulation studies. We consider the problem of testing symmetry through the hypothesis H 0 : γ = 0 against H 1 : γ = 0, for which the Wald-type test statistic W α,n is as given in (17) with γ 0 = 0. We first simulate random samples of sizes n = 50, 100 from the SN(0,1,0) distribution and perform the MDPDE based Waldtype test for different α, including the classical Wald test at α = 0. Based on 500 replications, we then compute the empirical levels of the tests measured as the proportion of test statistics exceeding the chisquare critical value among the 500 replications. Subsequently, to compute the empirical power of the tests, we repeat the above exercise but now generating random samples from an alternative SN(0,1,1) distribution.
Finally, to illustrate the claimed robustness, we recalculate the level and power of the Wald-type tests after contamination 100 % of each sample in the previous simulation exercises with = 0.05, 0.1. The contaminated observations are generated from SN(0,1,3) and SN(0,1,−3) distributions, (?????) respectively, for the level and power calculations. In Table 5 , we report all the resulting empirical levels and powers obtained from different simulation scenarios. with larger α. However, through more extensive simulations (not presented here for brevity) that the levels stabilizes to the desired 5% significance level for larger sample sizes; although this happens for the classical MLE based Wald test (at α = 0) at n = 100 itself, it needs much larger sample sizes to achieve desired level for larger values of α. As a results, the pure data power always appears higher for the Wald-type tests with larger α and they indeed becomes one for all α at moderately large sample sizes. However, the main advantage of the MDPDE based Wald-type tests appear at the stability of their levels and sizes under contamination in sample data. For Wald test at α = 0, the level inflates significantly due to contamination but becomes more stable with increasing α. Similarly, the power of the classical Wald test decreases drastically under contamination but regain its high values for the MDPDE based Wald-type tests with larger α ≥ 0.3.
Therefore the MDPDE based Wald-type tests with moderately large α > 0 always produce more power with a slightly inflated levels which remain stable even under different contamination levels.
6 Real Data Applications
AIS Dataset
Let us consider again the motivating dataset and use the MDPDE to obtain the estimates of the fitted SN distributions. We consider again the important health indicator variables as in Figure 2 and compute the MDPDEs of the parameters of the fitted SN distribution for each variable using the algorithm described in Section 3. We have also estimated the standard errors of the resulting MDPDEs using the formula described in Section 2.2. The parameter estimates, along with their standard errors, for all eight variables are reported in Table 6 . The outlier deleted MLE, obtained after removing the outliers identified through the respective box-plots, are also presented in Table 6 for reference.
It can be easily observed from Table 6 that To illustrate the robustness aspect of the MDPDEs more clearly, we have also recomputed the MDPDEs for outlier deleted data for all α ≥ 0 and compared them with the corresponding full data values; the greater robustness can be measured by the lower values of their relative differences defined as
where ν full and ν clean denote, respectively, the estimates of ν ∈ {µ, σ, γ} obtained from full data with outliers and the outlier deleted data. For all the eight measurements, the relative differences (RDs) of the MDPDEs over different α are plotted in Figure 5 . Clearly the RDs are significantly high for MLE (at α = 0); they are as high as 1200% and 400% for the skewness parameter γ for BMI and Wt, respectively. But these RDs decrease for MDPDEs as α > 0 increases and become very close to zero for α ≥ 0.5 in all the cases; they already become close to zero at α ≈ 0.2 for HC, RCC, WCC, LBM and Ht. Among three parameters, the effect of outliers is seen to be most significant for γ followed by σ and the effect is often minimum for the parameter µ. All these illustrations clearly show the claimed robustness of the proposed MDPDE with larger α > 0 for analyses of the present AIS dataset. 
For all these hypotheses, we have computed the p-values using the MDPDE based Wald-type tests for different α for the full data as well as the outlier-deleted data, which are plotted in Figure 6 . Note that, the usual Wald test at α = 0 is strongly affected by the outliers and provides completely opposite inference with clear difference in significance levels in presence or absence of outliers in most cases. However, the proposed MDPDE based tests with α > 0 provides stable inference similar to the one we could have obtained after removing the outliers for all the variables except PFC; for the testing problem in PFC, we need α ≥ 0.2 to have robust inference due to the excessive amount of contamination. Another interesting case is the one with Figure 6 : P-values obtained for different hypotheses testing problems for AIS data using the MDPDE based Wald-type tests for the full data (solid line) and the outlier-deleted data (dotted line).
AIDS Clinical Trial Data
Our second example is an AIDS clinical trial (ACTG 315) including 46 HIV-1 infected patients treated with a potent antiretroviral drug cocktail based on protease inhibitor and reverse transcriptase drugs (ritonavir, 3TC and AZT). During the study, the viral load, cd4 count (CD4) and cd8 count (CD8) were measured several times in different days from the start of the treatment (generally 4 to 10 measurements per patient)
The corresponding data has been analyzed by several statisticians [50] [51] [52] and is available in the R package 'qrNLMM '. In particular Castro [6] fitted the skew-normal distribution to this data in a regression settings.
Here, we consider the variable CD4, CD8 and the logarithm of the viral load (LGVIRAL) measured at 26 the second day after the start of the study for each patients. The corresponding histogram and the SN fit by the MLE is presented in Figure 7 ; clearly the distributions are skewed but the MLE is unable to fit them properly for CD8 and LGVIRAL due to the presence of outliers as shown in the respective box-plots in the same figure (Figure 7) . The MLE based fits are also shown in the figures along with the histogram, which clearly show the inability of the MLE to adequately model the bulk of the data due to the presence of few outlying points. In particular, the fitted SN distributions (by MLE) have a clearly different mode for both the measurements CD8 and LGVIRAL due to strong outlier effects. We next compute the proposed MDPDEs of the parameters of the fitted SN distribution for each of the three health measurements and compared them with the MLEs and the outlier deleted MLEs; the resulting estimates and their estimated standard errors are presented in Table 7 . From the table, we can see that the MDPDEs at any α > 0 are very similar to the MLE for CD4 where there are no outliers in the data. For
LGVIRAl, the MDPDEs with α ≥ 0.3 produce robust results which are significantly different from the MLE and are close to the outlier deleted MLE. For CD8, however, the MDPDEs with α ≥ 0.1 are all similar but significantly different from both the MLE as well as the outlier deleted MLE. To see which one provides the more robust fit, in Figure 8 , we have plotted the fitted SN density obtained by the MDPDE at α = 0.5, the MLE and the outlier deleted MLE, along with the histograms of CD8 and LGVIRAL. In both cases, the MDPDE seems to provide the best fit to the major bulk of the histogram, even better than the outlier 27 deleted MLE. This shows that there are yet other masked outliers in the data which are not detectable by the usual box-plot technique and hence illustrates the significance of our proposed MDPDEs over outlier deletion methods in providing stable inference from contaminated data. LGVIRAL and CD8 in AIDS clinical trial data.
28
Finally, as in the previous example, here also we have observed that the MDPDEs with α ≥ 0.3 are extremely stable in the presence and absence of the outliers, and produce robust inference for any parametric hypothesis testing problem for these clinical trial data as well. So, we have not presented them here for brevity.
Concluding remarks
In this paper, we have discussed new robust inference procedures for the SN distribution which is useful in modeling noisy skewed data through the popular minimum DPD approach. The minimum DPD estimators of the SN parameter are described along with their asymptotic and robustness properties and two efficient computational algorithms have been proposed. Then, we discuss the robust testing procedure through the MDPDE based Wald-type tests and their properties with detailed illustrations for testing symmetry against SN alternatives. The usefulness of the SN distribution and the proposed robust inference in the context of health data analysis are argued and illustrated empirically.
This work opens up several new directions in health research. The proposed methodology is a generalization of the MLE which can be extended to different inferential problems in health studies with skewed data to generate stable insight. For example, the immediate extension would be robust inference under regression models for skewedly distributed responses or comparing different populations of skewed data. The latter can be used in finding differential genes from expression data which are skewed in nature.
Although we have suggested some empirical choices for the tuning parameter α to be used in practice, more detailed research in this line would be necessary to develop an algorithm for data-driven selection of α; see, for example, [53] . We hope to pursue some of these extensions in our future work.
